Translational Research Institute (TRI)The TRI
will provide state-of-the-art core research facilities to facilitate
internationally competitive outcomes in translational and clinical
research. With a focus upon the fields of cancer, trauma, infectious
diseases, neuroscience, diabetes, obesity, cardiovascular disease, and
women’s and children’s health, the TRI will provide researchers with
ready access to facilities which would otherwise be unavailable, leading
to the translation of basic biomedical discoveries into new diagnostic
biomarkers and therapies.
The facility will consolidate all research groups across HMC, and
encourage collaboration and innovation through a number of cross-cutting
themes such as bioinformatics, ethics, molecular imaging, functional
genomics, proteomics and metabolomics, clinical imaging, clinical trials
and biostatistics.
As a key component of the Academic Health System, the TRI will
facilitate HMC’s development as an internationally-recognized health
research organization and the leading health research organization in
the Gulf region. The TRI will complement the other major biomedical
research facilities in Qatar, including state-of-the-art core research
facilities established at Weill Cornell Medical College in Qatar
(WCMC-Q). The institute will also host Biobank Qatar, funded by the
Qatar Foundation, which will include a prospective epidemiological study
on the Qatari population (in collaboration with Imperial College
London) and a disease specific tissue repository.
